Daily tablet for advanced breast cancer patients set for NHS rollout
Elacestrant is recommended for patients whose cancer has worsened after at least a year of treatment with hormone therapy and CDK4/6 inhibitor.
Continue reading this article about Daily tablet for advanced breast cancer patients set for NHS rollout
by Storm Newton
NHS Forums - For daily discussion by NHS Staff.
Elacestrant is recommended for patients whose cancer has worsened after at least a year of treatment with hormone therapy and CDK4/6 inhibitor.
Continue reading this article about Daily tablet for advanced breast cancer patients set for NHS rollout
by Storm Newton
NHS Forums - For daily discussion by NHS Staff.